MARKET

ACXP

ACXP

Acurx Pharmaceuticals Inc
NASDAQ
3.480
+0.200
+6.10%
After Hours: 3.510 +0.03 +0.86% 19:54 12/04 EST
OPEN
3.250
PREV CLOSE
3.280
HIGH
3.500
LOW
3.173
VOLUME
43.26K
TURNOVER
--
52 WEEK HIGH
25.80
52 WEEK LOW
3.171
MARKET CAP
7.26M
P/E (TTM)
-0.4073
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ACXP last week (1124-1128)?
Weekly Report · 4d ago
Weekly Report: what happened at ACXP last week (1117-1121)?
Weekly Report · 11/24 10:33
New to The Street Show #702 Airs Today on Bloomberg at 6:30 PM EST
Barchart · 11/22 05:20
Acurx Pharmaceuticals and Leiden University Medical Center Secure $375,000 Health~Holland Grant for Antibiotic Research
Reuters · 11/18 13:03
Weekly Report: what happened at ACXP last week (1110-1114)?
Weekly Report · 11/17 10:33
New to The Street Airs Landmark Show #700 Today at 6:30 PM ET on Bloomberg Television
Barchart · 11/15 06:10
Acurx Pharmaceuticals: Promising Developments and Strategic Advances in Antibiotic Innovation
TipRanks · 11/13 16:45
Acurx Pharmaceuticals Reports Q3 2025 Financial Results
TipRanks · 11/13 04:35
More
About ACXP
Acurx Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections. It develops antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its research and development (R&D) pipeline include antibiotic product candidates that target Gram-positive bacteria, including Clostridioides difficile (C. difficile), methicillin-resistant Staphylococcus aureus (MRSA), vancomycin resistant Enterococcus (VRE), drug-resistant Streptococcus pneumoniae (DRSP) and B. anthracis (anthrax; a Bioterrorism Category A Threat-Level pathogen). Its lead antibiotic candidate, ibezapolstat targets the pol IIIC enzyme.

Webull offers Acurx Pharmaceuticals Inc stock information, including NASDAQ: ACXP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACXP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ACXP stock methods without spending real money on the virtual paper trading platform.